SEC Filing Analysis: CalciMedica, Inc.

Executive Summary

• Trading Significance: High
• Key Takeaway: Individual investor Jorey Chernett has disclosed a new 7.88% passive ownership stake in CalciMedica, Inc., representing a significant vote of confidence in the small-cap company.
• Market Impact: The establishment of a new, large individual shareholder position is a bullish signal that could increase investor attention and confidence in the stock.

Company Information

Field	Value
Company	CalciMedica, Inc.
Ticker Symbol	Not provided in filing
CIK	0001534133
Industry	PHARMACEUTICAL PREPARATIONS

Filer Information

Field	Value
Name	Chernett Jorey
CIK	0002042077
Title/Position	Individual Investor
Relationship	10% Owner

Filing Details

Field	Value
Form Type	SCHEDULE 13G
Event Date	2025-11-24
Security Type	Common Stock
Shares Beneficially Owned	1,134,847
Percent of Class	7.88%
Ownership Type	Direct

Financial Impact Assessment

Position Materiality

Metric	Value
Company Market Cap	$40,000,000
Total Shares Owned	1,134,847
Percent of Company Owned	7.88%
Approximate Stake Value	$3,152,000 (7.88% of $40M Market Cap)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For a company with a $40 million market capitalization, a single individual's stake valued at over $3.1 million is substantial. This represents a significant concentration of capital and conviction.
• Ownership Concentration: The filing establishes Jorey Chernett as a major shareholder. Any future buying or selling by this individual will be closely watched by the market.
• Transaction Significance: The crossing of the 5% beneficial ownership threshold is a mandatory disclosure event and is considered highly significant, as it introduces a new major player in the company's ownership structure.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral to Positive
• Reasoning: This Schedule 13G filing indicates a passive investment intent, not an activist campaign. However, the establishment of a large new position by an individual investor is often interpreted by the market as a bullish signal, reflecting deep conviction in the company's future prospects.

Volume & Sentiment

• Expected Volume Impact: May see a near-term increase in trading volume as the market digests the news of a new significant shareholder.
• Sentiment Indicator: Bullish. A new, multi-million dollar stake in a small-cap company is a strong positive sentiment indicator.

Investment Insights

Positive Market Indicators

• A new individual investor has acquired a substantial 7.88% stake, indicating strong belief in the company's value.
• The stake's value (approx. $3.15M) is significant relative to the company's micro-cap status, suggesting a high-conviction investment.

Risk Factors

• As a passive investor, the filer is not expected to influence company strategy. The investment thesis is not publicly known.

Key Takeaways

1. New Major Shareholder: Jorey Chernett is now a significant owner of CalciMedica, holding 7.88% of its common stock.
2. High-Conviction Stake: The position is valued at approximately $3.15 million, a material investment in a $40 million company.
3. Passive Intent: The 13G filing certifies that the shares were not acquired for the purpose of changing or influencing control of the company.

Additional Context

Transaction Notes

• This filing reports reaching a beneficial ownership level, with the event triggering the filing occurring on November 24, 2025. It does not represent a single transaction but the cumulative ownership crossing the 5% reporting threshold.